Publications by authors named "Emiliano Cocco"

67Publications

FOXA1 Mutations Reveal Distinct Chromatin Profiles and Influence Therapeutic Response in Breast Cancer.

Cancer Cell 2020 Oct 3;38(4):534-550.e9. Epub 2020 Sep 3.

Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2020.08.003DOI Listing
October 2020

Prevalence and role of HER2 mutations in cancer.

Pharmacol Ther 2019 07 2;199:188-196. Epub 2019 Apr 2.

Human Oncology & Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01637258193005
Publisher Site
http://dx.doi.org/10.1016/j.pharmthera.2019.03.010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571037PMC
July 2019

PI3K Inhibition Activates SGK1 via a Feedback Loop to Promote Chromatin-Based Regulation of ER-Dependent Gene Expression.

Cell Rep 2019 04;27(1):294-306.e5

Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 20, New York, NY 10065, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA; Research & Development Oncology, AstraZeneca Pharmaceuticals, Gaithersburg, MD 20878, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S22111247193029
Publisher Site
http://dx.doi.org/10.1016/j.celrep.2019.02.111DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503687PMC
April 2019

NTRK fusion-positive cancers and TRK inhibitor therapy.

Nat Rev Clin Oncol 2018 12;15(12):731-747

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41571-018-0113-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6419506PMC
December 2018

Improved i.p. drug delivery with bioadhesive nanoparticles.

Proc Natl Acad Sci U S A 2016 10 23;113(41):11453-11458. Epub 2016 Sep 23.

Department of Biomedical Engineering, Yale University, New Haven, CT 06511; Department of Chemical & Environmental Engineering, Yale University, New Haven, CT 06511

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1523141113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5068292PMC
October 2016

Improved specific loss power on cancer cells by hyperthermia and MRI contrast of hydrophilic Fe Co Fe O nanoensembles.

Contrast Media Mol Imaging 2016 11 22;11(6):514-526. Epub 2016 Sep 22.

Magnetic Resonance Research Center (MRRC) and Quantitative Neuroscience with Magnetic Resonance (QNMR) Core Center, Yale University, New Haven, CT, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cmmi.1713DOI Listing
November 2016

Neratinib shows efficacy in the treatment of HER2 amplified carcinosarcoma in vitro and in vivo.

Gynecol Oncol 2015 Oct 8;139(1):112-7. Epub 2015 Aug 8.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, 333 Cedar Street New Haven, CT 06520, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.08.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587290PMC
October 2015

Polymerase ε (POLE) ultra-mutated tumors induce robust tumor-specific CD4+ T cell responses in endometrial cancer patients.

Gynecol Oncol 2015 Jul 27;138(1):11-7. Epub 2015 Apr 27.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, 333 Cedar Street, PO Box 208063, New Haven, CT 06520-8063, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2015.04.027DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4469551PMC
July 2015

Clostridium perfringens enterotoxin (CPE) and CPE-binding domain (c-CPE) for the detection and treatment of gynecologic cancers.

Toxins (Basel) 2015 Apr 1;7(4):1116-25. Epub 2015 Apr 1.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, 333 Cedar Street, PO Box 208063, New Haven, CT 06520-8063, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/toxins7041116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417958PMC
April 2015

Taselisib, a selective inhibitor of PIK3CA, is highly effective on PIK3CA-mutated and HER2/neu amplified uterine serous carcinoma in vitro and in vivo.

Gynecol Oncol 2014 Nov 27;135(2):312-7. Epub 2014 Aug 27.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, 333 Cedar Street, PO Box 208063, New Haven, CT 06520-8063, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2014.08.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270135PMC
November 2014

Neratinib shows efficacy in the treatment of HER2/neu amplified uterine serous carcinoma in vitro and in vivo.

Gynecol Oncol 2014 Oct 12;135(1):142-8. Epub 2014 Aug 12.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00908258140125
Publisher Site
http://dx.doi.org/10.1016/j.ygyno.2014.08.006DOI Listing
October 2014

Protective effect of mitochondrial ferritin on cytosolic iron dysregulation induced by doxorubicin in HeLa cells.

Mol Biol Rep 2013 Dec 25;40(12):6757-64. Epub 2013 Sep 25.

Molecular and Translational Medicine Department, University of Brescia, Viale Europa 11, 25123, Brescia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11033-013-2792-zDOI Listing
December 2013

HER2/neu gene amplification determines the sensitivity of uterine serous carcinoma cell lines to AZD8055, a novel dual mTORC1/2 inhibitor.

Gynecol Oncol 2013 Dec 4;131(3):753-8. Epub 2013 Sep 4.

Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, 333 Cedar Street, PO Box 208063, New Haven, CT 06520-8063, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2013.08.033DOI Listing
December 2013

Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone.

Am J Obstet Gynecol 2013 Jul 10;209(1):62.e1-9. Epub 2013 Apr 10.

Division of Gynecologic Oncology, Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajog.2013.04.017DOI Listing
July 2013

Serum amyloid A: a novel biomarker for endometrial cancer.

Cancer 2010 Feb;116(4):843-51

Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut 06520-8063, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.24838
Publisher Site
http://dx.doi.org/10.1002/cncr.24838DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819580PMC
February 2010

The effects of frataxin silencing in HeLa cells are rescued by the expression of human mitochondrial ferritin.

Biochim Biophys Acta 2008 Feb 5;1782(2):90-8. Epub 2007 Dec 5.

Dipartimento Materno Infantile e Tecnologie Biomediche, Università di Brescia, Viale Europa 11, Brescia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbadis.2007.11.006DOI Listing
February 2008